Amphastar Pharmaceuticals Priced, Nasdaq: AMPH
Produces difficult-to-manufacture injectable and inhalable drugs.
Industry: Health Care
First Day Return: +25.0%
AMPH
Produces difficult-to-manufacture injectable and inhalable drugs.
| IPO Data | |
|---|---|
| IPO Date | 06/24/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $56 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Rancho Cucamonga, CA, United States |
| Founded | 1996 |
| Employees at IPO | 1,217 |
| Website www.amphastar.com | |
IPO News for Amphastar Pharmaceuticals
Amphastar Pharmaceuticals (AMPH) Performance
